Use of high-flow oxygen was associated with less of a need for mechanical ventilation and a shorter time to recovery compared with conventional oxygen therapy in patients with severe COVID-19, a ...

Please provide your email address to receive an email when new articles are posted on . Infants with bronchiolitis who are treated with high-flow oxygen therapy are less likely to require increased ...

Study finds that high-flow nasal oxygen therapy is as effective as traditional noninvasive ventilation and a better alternative (1 Trusted Source High-Flow Nasal Oxygen vs Noninvasive Ventilation in ...

This was a multicenter, randomized trial comparing a "standard" therapy group of patients receiving supplemental oxygen via nasal cannula and a "high-flow" therapy group of patients receiving ...

The conclusion was that titrating oxygen administration to adequate levels, as recommended in guidelines, [1] is safer than administering oxygen at high flow rates to patients with COPD who may have ...

Please provide your email address to receive an email when new articles are posted on . Children aged 1 to 4 years with acute hypoxemic respiratory failure did not experience shorter hospital stays on ...

Children, as well as their parents, may one day be able to breathe a little easier: The respiratory therapy company Vapotherm said a pilot study of its high-flow treatment showed it could outperform ...

To the Editor: In the article by Franklin et al. (March 22 issue), 1 in which infants with bronchiolitis were assigned to receive low-flow oxygen (standard-therapy group) or high-flow oxygen ...

Hypoxemia is the most common complication of emergency endotracheal intubation of children, with an incidence of up to 50%. In this randomized trial of children under 16 years, nasal high-flow oxygen ...

Respiratory care specialist Vapotherm raised $56 million in an initial public offering of 4 million shares, priced at the low end of the range at $14. The Exeter, New Hampshire-based company plans to ...

NEWARK, Del, June 21, 2023 (GLOBE NEWSWIRE) -- The high-flow oxygen therapy devices market is forecast to expand at 0.5% CAGR over the estimated period, as per FMI's analysis. The industry's size is ...